APAC CRO MARKET
Get instant access to latest e-book

latest newsRead more...

12

Dec 2018

Oxforb BioTherapeutics expands its strategic collaboration with WuXi Biologics

WuXi Biologics HK a leading global open source biological technology platform company offering integrated solutions for discovery development and biological and Oxford manufacturing BioTherapeutics Ltd OBT a clinical stage oncology company with a portfolio of immunooncological treatments and joint antibody drugs today announced the expansion…

12

Dec 2018

Vect-Horus Announces Agreement With Johnson & Johnson Innovation

VectHorus announced today the signing of a research collaboration agreement with Janssen Pharmaceuticals Inc one of the Janssen Pharmaceutical Companies of Johnson Johnson The goal of this collaboration is to use VectHorus proprietary technology to transport various Janssen monoclonal antibodies to the brain for the…

11

Dec 2018

GeneCentric Therapeutics Enters Bladder Cancer Research Collaboration with University of North Carolina

GeneCentric Therapeutics Inc today announced that it has entered into a research collaboration with the University of North Carolina at Chapel Hill UNC to assess patient response to immunotherapeutic drugs such as PD and PDL inhibitors based on bladder cancer subtypes The collaboration will augment…

11

Dec 2018

HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation President and CEO Masayuki Mitsuka Headquarters Osaka MTPC to identify novel small molecule leads for targets of interest According to the agreement HitGen will apply its…

10

Dec 2018

WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing announced today a strategic collaboration with Brii Biosciences Brii Bio an innovative biotechnology company operates in China and the US focusing on accelerating innovation and optimizing…

press releasesRead more...

12

Dec 2018

WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity

WuXi Biologics HK a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing today announced that it has achieved a breakthrough in cell…

12

Dec 2018

Amgen And Magellan Rx Management Collaborate To Improve Patient Care For Chronic, Difficult-To-Treat Conditions

Amgen today announced a novel multiyear collaboration with Magellan Rx Management the pharmacy benefit management division of Magellan Health that will leverage each companys capabilities and resources to identify clinical…

11

Dec 2018

Bragar Eagel & Squire, P.C. is Investigating Teladoc Health, Inc. (TDOC) on Behalf of Stockholders and Encourages TDOC Investors to Contact the Firm

NEW YORK Dec GLOBE NEWSWIRE Bragar Eagel Squire PC is investigating potential claims against Teladoc Health Inc NYSE TDOC Our investigation concerns whether Teladoc has violated the federal securities laws…

11

Dec 2018

Merck and genOway enter into a strategic alliance to develop rodent models using CRISPR / Cas9

Merck a leading science and technology company and pioneer in genome editing today announced a strategic alliance with French biotechnology company genOway in the market for CRISPR Casbased rodent models…

11

Dec 2018

Tissue Regeneration Therapeutics and RoosterBio Inc. Form Strategic Alliance to Commercialize Umbilical Cord Tissue Cell Technology

Today Tissue Regeneration Therapeutics Inc TRT and RoosterBio Inc RBI announce an important strategic alliance to advance their shared goal of accelerating the development of the Regenerative Medicine and Cellular…

EventsRead more...

09-13

Dec 2018

Antibody Engineering & Therapeutics

KNect365
Manchester Grand Hyatt San Diego

12-13

Dec 2018

3rd New Product Planning Summit

ExL Events, Inc.
Hilton Boston Back Bay

13-14

Dec 2018

13-15

Dec 2018

Advances in Inflammatory Bowel Diseases

Imedex
Walt Disney World Dolphin Hotel

TOP ARTICLES

  • 3

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
  • 5

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..

Knowledge Bank

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia
    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..

  • Articles

    SPC and Evaluation of Analyst Performance

    Introduction Statistical Process Control SPC has become valuable tools in different areas in human life notably healthcare industry including the pharmaceutical field In general SPC provides a visually quantitative measure for specifically monitored inspection properties Accordingly it assesses the degree of control on the investigated characteristic efficiency staebility quality any improvements required and the…

  • Techno Trends

    Alnylam’s ONPATTRO to Treat Patients with Hereditary ATTR Amyloidosis in Adults

    Alnylams ONPATTRO patisiran lipid complex injection is a firstofitskind RNA interference RNAi therapeutic used to treat the polyneuropathy of hereditary transthyretinmediated hATTR Amyloidosis in adults RNAi is a completely new approach to the treatment of these diseases targeting the faulty protein that is causing the disease rather than treating the symptoms RNAi therapeutic is an entirely new class of medicines…

Editorial Section

  • Strategy

    Statin Drug Interactions and Related Adverse Reactions

    Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting…

  • Research development

    Stem Cell and Gene Delivery

    These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem…

  • Clinical Trials

    Managing Clinical Trial Agreements

    Clinical Trial Agreements set out how a clinical trial will be run at the site and are an essential GCP document There are a number of key factors that determine whether a Clinical Trial Agreement is successful in achieving that…

  • Information Technology

    R&D DATA HUB

    Faster decision making and better trial oversight at all levels requires truly next generation data integration and analytics Source and format agnostic data aggregation aided by modern data lake architecture and advanced analytics deliver interactive…

TOP